Matthew A. Lawlor
Markey Cancer Center(US)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, RNA modifications and cancer, Epigenetics and DNA Methylation
Most-Cited Works
- → The dTAG system for immediate and target-specific protein degradation(2018)1,124 cited
- → Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies(2019)352 cited
- → Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma(2018)240 cited
- → Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands(2018)223 cited
- → Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia(2018)170 cited
- → Small-molecule targeting of brachyury transcription factor addiction in chordoma(2019)163 cited
- → Synthetic transcription elongation factors license transcription across repressive chromatin(2017)141 cited
- → Therapy-induced APOBEC3A drives evolution of persistent cancer cells(2023)135 cited
- → Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer(2016)126 cited
- → BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models(2019)80 cited